Waters
Advertisement
Articles by Waters
QC Analysis of Oligonucleotide Therapeutics: One Platform Method for Determining Identity, Purity, and Quantity
ByWaters
Thursday, June 23, 2022 at 10am ET | 3pm BST | 4pm CEST Join us on June 23 to learn about QC Analysis of Oligonucleotide Therapeutics. One Platform Method for Determining Identity, Purity, and Quantity.
Understand challenges posed by updated E&L guidance for medical devices (ISO 10990-18) Insight into considerations for analytical setup that impact regulatory compliance Overview of materials E&L risk profiles and testing requirements
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
4
Sustainability and Stability in Excipients
5
